Practical chemical and enzymatic technologies for (S)-1,4-benzodioxan-2-carboxypiperizine intermediate in the synthesis of (S)-doxazosin mesylate

被引:29
作者
Fang, QK [1 ]
Grover, P [1 ]
Han, ZX [1 ]
McConville, FX [1 ]
Rossi, RF [1 ]
Olsson, DJ [1 ]
Kessler, DW [1 ]
Wald, SA [1 ]
机构
[1] Sepracor Inc, Chem Proc Res & Dev, Marlborough, MA 01752 USA
关键词
D O I
10.1016/S0957-4166(01)00368-8
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
(S)-1,4-Benzodioxan-2-carboxypiperazine (S)-2, the key chiral intermediate for the synthesis of (S)-doxazosin, was prepared utilizing two approaches: (i) enzymatic resolution of ethyl 1,4-benzodioxan-2-carboxylate with an esterase (Serratia) followed by an-de formation; (ii) direct resolution of 1,4-benzodioxan-2-carboxypiperazine 2 with D-tartaric acid. An efficient process for the conversion of (S)-2 to (S)-doxazosin mesylate was developed (80% yield, 99.9% e.e.). (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2169 / 2174
页数:6
相关论文
共 15 条
[1]   SYNTHESIS AND IDENTIFICATION OF MAJOR METABOLITES OF PRAZOSIN FORMED IN DOG AND RAT [J].
ALTHUIS, TH ;
HESS, HJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (01) :146-149
[2]   2,4-DIAMINO-6,7-DIMETHOXYQUINAZOLINES .1. 2-[4-(1,4-BENZODIOXAN-2-YLCARBONYL)PIPERAZIN-1-YL] DERIVATIVES AS ALPHA-1-ADRENOCEPTOR ANTAGONISTS AND ANTIHYPERTENSIVE AGENTS [J].
CAMPBELL, SF ;
DAVEY, MJ ;
HARDSTONE, JD ;
LEWIS, BN ;
PALMER, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (01) :49-57
[3]   QUANTITATIVE-ANALYSES OF BIOCHEMICAL KINETIC RESOLUTIONS OF ENANTIOMERS [J].
CHEN, CS ;
FUJIMOTO, Y ;
GIRDAUKAS, G ;
SIH, CJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1982, 104 (25) :7294-7299
[4]   HMDS-promoted in situ amidation reactions of carboxylic acids and amines [J].
Chou, WC ;
Chou, MC ;
Lu, YY ;
Chen, SF .
TETRAHEDRON LETTERS, 1999, 40 (17) :3419-3422
[5]   One-pot neat reactions of carboxylic esters and alkylenediamines for efficient preparation of N-acylalkylenediamines [J].
Chou, WC ;
Tan, CW ;
Chen, SF ;
Ku, H .
JOURNAL OF ORGANIC CHEMISTRY, 1998, 63 (26) :10015-10017
[6]  
ELLIOT HL, 1987, AM J CARDIOL, V59, pG79
[7]   A multicenter, community-based study of doxazosin in the treatment of concomitant hypertension and symptomatic benign prostatic hyperplasia: The Hypertension and BPH Intervention Trial (HABIT) [J].
Guthrie, RM ;
Siegel, RL .
CLINICAL THERAPEUTICS, 1999, 21 (10) :1732-1748
[8]  
HOKANEN E, 1980, J HETEROCYCLIC CHEM, V17, P797
[9]  
Jacques J., 1981, ENANTIOMERS RACEMATE, P32
[10]  
Kirby RS, 1998, INT J CLIN PRACT, V52, P402